Maternal environment interacts with modifier genes to influence progression of nephrotic syndrome.

Mutations in the NPHS2 gene, which encodes podocin, are responsible for some cases of sporadic and familial autosomal recessive steroid-resistant nephrotic syndrome. Inter- and intrafamilial variability in the progression of renal disease among patients bearing NPHS2 mutations suggests a potential role for modifier genes. Using a mouse model in which the podocin gene is constitutively inactivated, we sought to identify genetic determinants of the development and progression of renal disease as a result of the nephrotic syndrome. We report that the evolution of renal disease as a result of nephrotic syndrome in Nphs2-null mice depends on genetic background. Furthermore, the maternal environment significantly interacts with genetic determinants to modify survival and progression of renal disease. Quantitative trait locus mapping suggested that these genetic determinants may be encoded for by genes on the distal end of chromosome 3, which are linked to proteinuria, and on the distal end of chromosome 7, which are linked to a composite trait of urea, creatinine, and potassium. These loci demonstrate epistatic interactions with other chromosomal regions, highlighting the complex genetics of renal disease progression. In summary, constitutive inactivation of podocin models the complex interactions between maternal and genetically determined factors on the progression of renal disease as a result of nephrotic syndrome in mice.

[1]  J. Owens,et al.  Normal lactational environment restores nephron endowment and prevents hypertension after placental restriction in the rat. , 2007, Journal of the American Society of Nephrology : JASN.

[2]  F. Hildebrandt,et al.  Nephrotic Syndrome in the First Year of Life: Two Thirds of Cases Are Caused by Mutations in 4 Genes (NPHS1, NPHS2, WT1, and LAMB2) , 2007, Pediatrics.

[3]  C. Lewis,et al.  Genome scan of glomerular filtration rate and albuminuria: the HyperGEN study. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  E. Boerwinkle,et al.  Influence of genomic loci on measures of chronic kidney disease in hypertensive sibships. , 2006, Journal of the American Society of Nephrology : JASN.

[5]  J. Rossant,et al.  Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. , 2006, Journal of the American Society of Nephrology : JASN.

[6]  E. Christensen,et al.  Renal albumin absorption in physiology and pathology. , 2006, Kidney international.

[7]  Sebastian Amigorena,et al.  Lactadherin promotes VEGF-dependent neovascularization , 2005, Nature Medicine.

[8]  X. Cui,et al.  Kinesin family member 12 is a candidate polycystic kidney disease modifier in the cpk mouse. , 2005, Journal of the American Society of Nephrology : JASN.

[9]  P. Pavlidis,et al.  A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  W. Deen What determines glomerular capillary permeability? , 2004, The Journal of clinical investigation.

[11]  O. Gribouval,et al.  NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. , 2004, Kidney international.

[12]  A. Bakkaloğlu,et al.  Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. , 2004, Journal of the American Society of Nephrology : JASN.

[13]  V. D’Agati,et al.  Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Kretzler,et al.  Early Glomerular Filtration Defect and Severe Renal Disease in Podocin-Deficient Mice , 2004, Molecular and Cellular Biology.

[15]  X. Montagutelli,et al.  Genetic interaction between a maternal factor and the zygotic genome controls the intestine length in PRM/Alf mice. , 2003, Physiological genomics.

[16]  Robert W. Williams,et al.  The nature and identification of quantitative trait loci: a community's view , 2003, Nature Reviews Genetics.

[17]  R. Akhurst,et al.  Genetic modifiers interact with maternal determinants in vascular development of Tgfb1(-/-) mice. , 2003, Human molecular genetics.

[18]  G. Mazzucco,et al.  Broadening the spectrum of diseases related to podocin mutations. , 2003, Journal of the American Society of Nephrology : JASN.

[19]  C. ffrench-Constant,et al.  Mice Lacking the Giant Protocadherin mFAT1 Exhibit Renal Slit Junction Abnormalities and a Partially Penetrant Cyclopia and Anophthalmia Phenotype , 2003, Molecular and Cellular Biology.

[20]  G. Striker,et al.  Resistance to glomerulosclerosis in B6 mice disappears after menopause. , 2003, The American journal of pathology.

[21]  Keiko Miwa,et al.  Identification of a factor that links apoptotic cells to phagocytes , 2002, Nature.

[22]  J. Miner,et al.  Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome. , 2002, The American journal of pathology.

[23]  F. Hildebrandt,et al.  Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. , 2002, Journal of the American Society of Nephrology : JASN.

[24]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[25]  M. Saleem,et al.  Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. , 2001, The Journal of clinical investigation.

[26]  T. Benzing,et al.  Interaction with Podocin Facilitates Nephrin Signaling* , 2001, The Journal of Biological Chemistry.

[27]  A. Woolf,et al.  Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions. , 2001, The American journal of pathology.

[28]  T. Graf,et al.  Anuria, Omphalocele, and Perinatal Lethality in Mice Lacking the Cd34-Related Protein Podocalyxin , 2001, The Journal of experimental medicine.

[29]  R. Ramirez-Solis,et al.  Proteinuria and Perinatal Lethality in Mice Lacking NEPH1, a Novel Protein with Homology to NEPHRIN , 2001, Molecular and Cellular Biology.

[30]  O. Gribouval,et al.  Clinical and genetic evaluation of familial steroid-responsive nephrotic syndrome in childhood. , 2001, Journal of the American Society of Nephrology : JASN.

[31]  M. Hamosh,et al.  Bioactive factors in human milk. , 2001, The Pediatric clinics of North America.

[32]  Corinne Antignac,et al.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome , 2000, Nature Genetics.

[33]  T. Morita,et al.  Mesangiolysis: an update. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  N. Khatibi,et al.  Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice. , 1997, The Journal of clinical investigation.

[35]  W. Couser,et al.  Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus. , 1997, The Journal of clinical investigation.

[36]  R. Doerge,et al.  Empirical threshold values for quantitative trait mapping. , 1994, Genetics.

[37]  J. Rozing,et al.  Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[38]  O. Gribouval,et al.  Podocin localizes in the kidney to the slit diaphragm area. , 2002, The American journal of pathology.

[39]  K. Tryggvason,et al.  The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. , 2001, Human molecular genetics.